Looking for Lilly’s LY4086940? Its two registered trials, NCT06945419 and NCT07890376, are listed below. For what they test and what has not been disclosed, see the LY4086940 profile or our LY4086940 write-up.
3 registered trials, newest registry update first. Showing only trials linked to AOD-9604.
| Trial | Compound | Phase | Status | Sponsor | Enrolled | Primary completion | Registry updated |
|---|---|---|---|---|---|---|---|
| A Two-part Proof-of-Concept Study Assessing the Safety and Efficacy of LAT8881 in Lumbar Radicular Pain NCT05298306 | AOD-9604 | Phase 1 | Completed | Lateral Pharma Pty Ltd | 26 | May 12, 2023 | Nov 27, 2024 |
| Oral LAT8881 in Neuropathic Pain NCT03865953 | AOD-9604 | Phase 2 | Completed | Lateral Pharma Pty Ltd | 53 | Apr 19, 2020 | Jun 14, 2021 |
| A Proof of Concept Study of the Efficacy and Safety of Oral LAT8881 in Acute Migraine NCT04153409 | AOD-9604 | Phase 2 | Completed | Lateral Pharma Pty Ltd | 21 | Feb 15, 2020 | Apr 28, 2021 |
Data: ClinicalTrials.gov, U.S. National Library of Medicine. Registered trials only. This table does not report results or recommend anything.